Saray Garasa

3.8k total citations
36 papers, 2.1k citations indexed

About

Saray Garasa is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Saray Garasa has authored 36 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 23 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Saray Garasa's work include Immunotherapy and Immune Responses (19 papers), CAR-T cell therapy research (13 papers) and Immune Cell Function and Interaction (13 papers). Saray Garasa is often cited by papers focused on Immunotherapy and Immune Responses (19 papers), CAR-T cell therapy research (13 papers) and Immune Cell Function and Interaction (13 papers). Saray Garasa collaborates with scholars based in Spain, United Kingdom and United States. Saray Garasa's co-authors include Ignacio Melero, Álvaro Teijeira, José Luis Perez‐Gracia, Ana Rouzaut, Pedro Berraondo, Alfonso R. Sánchez-Paulete, María C. Ochoa, Miguel F. Sanmamed, Arantza Azpilikueta and Inmaculada Rodríguez and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Saray Garasa

36 papers receiving 2.1k citations

Peers

Countries citing papers authored by Saray Garasa

Since Specialization

Citations

This map shows the geographic impact of Saray Garasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saray Garasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saray Garasa more than expected).

Fields of papers citing papers by Saray Garasa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saray Garasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saray Garasa. The network helps show where Saray Garasa may publish in the future.

Co-authorship network of co-authors of Saray Garasa

This figure shows the co-authorship network connecting the top 25 collaborators of Saray Garasa. A scholar is included among the top collaborators of Saray Garasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saray Garasa. Saray Garasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy 2023 ·Cell Reports Medicine ·Irene Olivera, Elixabet Bolaños, (unknown), Sandra Hervás‐Stubbs, Karina V. Mariño, Carlos Luri‐Rey, Iñaki Etxeberría, Assunta Cirella, Josune Egea, Javier Glez‐Vaz, Saray Garasa, Maite Álvarez, Iñaki Eguren‐Santamaría, Sònia Guedan, Miguel F. Sanmamed, Pedro Berraondo, Gabriel A. Rabinovich, Álvaro Teijeira, Ignacio Melero	32
2	Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic 2023 ·OncoImmunology ·Maite Álvarez, Carmen Molina, Saray Garasa, María C. Ochoa, María E. Rodríguez-Ruiz, (unknown), Assunta Cirella, Irene Olivera, Javier Glez‐Vaz, (unknown), Carlos Luri‐Rey, Arantza Azpilikueta, Elixabet Bolaños, Álvaro Teijeira, Pedro Berraondo, Marisol Quintero, Ignacio Melero	10
3	Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma 2023 ·Cell Reports Medicine ·María C. Ochoa, (unknown), Carlos E. de Andrea, Saray Garasa, Maite Álvarez, Irene Olivera, Javier Glez‐Vaz, Carlos Luri‐Rey, Iñaki Etxeberría, Assunta Cirella, Arantza Azpilikueta, Pedro Berraondo, Josepmaria Argemí, Bruno Sangro, Álvaro Teijeira, Ignacio Melero	16
4	Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists 2023 ·Molecular Therapy — Nucleic Acids ·Assunta Cirella, Elixabet Bolaños, Carlos Luri‐Rey, (unknown), Irene Olivera, (unknown), Javier Glez‐Vaz, (unknown), Saray Garasa, (unknown), Arantza Azpilikueta, Iñaki Eguren‐Santamaría, Karmele Valencia, Belén Palencia, Maite Álvarez, María C. Ochoa, Álvaro Teijeira, Pedro Berraondo, Ignacio Melero	6
5	Intratumoral co‐injection of NK cells and NKG2A ‐neutralizing monoclonal antibodies 2023 ·EMBO Molecular Medicine ·Ignacio Melero, María C. Ochoa, Carmen Molina, (unknown), Saray Garasa, Carlos Luri‐Rey, Sandra Hervás‐Stubbs, Noëlia Casares, (unknown), (unknown), Assunta Cirella, Pedro Berraondo, Álvaro Teijeira, Maite Álvarez	13
6	Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy 2022 ·Cancer Research ·Álvaro Teijeira, Saray Garasa, Carlos Luri‐Rey, Carlos de Andrea, María Gato, Carmen Molina, Tsuneyasu Kaisho, Assunta Cirella, Arantza Azpilikueta, Stefanie K. Wculek, Josune Egea, Irene Olivera, Inmaculada Rodríguez, Ana Rouzaut, Vladislav V. Verkhusha, Karmele Valencia, David Sancho, Pedro Berraondo, Ignacio Melero	22
7	Differential Interleukin‐8 thresholds for chemotaxis and netosis in human neutrophils 2021 ·European Journal of Immunology ·Álvaro Teijeira, Saray Garasa, María C. Ochoa, Assunta Cirella, Irene Olivera, Javier Glez‐Vaz, Maria Pilar Andueza, Itziar Miguéliz, Maite Álvarez, María E. Rodríguez-Ruiz, Ana Rouzaut, Pedro Berraondo, Miguel F. Sanmamed, José Luis Perez‐Gracia, Ignacio Melero	41
8	Cellular cytotoxicity is a form of immunogenic cell death 2020 ·Journal for ImmunoTherapy of Cancer ·Luna Minute, Álvaro Teijeira, Alfonso R. Sánchez-Paulete, María C. Ochoa, Maite Álvarez, Itziar Otano, (unknown), Elixabet Bolaños, Arantza Azpilikueta, Saray Garasa, Noëlia Casares, José Luis Perez‐Gracia, María E. Rodríguez-Ruiz, Pedro Berraondo, Ignacio Melero	71
9	Metabolic Consequences of T-cell Costimulation in Anticancer Immunity 2019 ·Cancer Immunology Research ·Álvaro Teijeira, Saray Garasa, Iñaki Etxeberría, María Gato, Ignacio Melero, Greg M. Delgoffe	53
10	Immunotherapeutic effects of intratumoral nanoplexed poly I:C 2019 ·Journal for ImmunoTherapy of Cancer ·M. Ángela Aznar, Lourdes Planelles, (unknown), Carmen Molina, Saray Garasa, Iñaki Etxeberría, Guiomar Pérez, Inmaculada Rodríguez, Elixabet Bolaños, Pedro P. López‐Casas, María E. Rodríguez-Ruiz, José Luis Perez‐Gracia, Iván Márquez‐Rodas, Álvaro Teijeira, Marisol Quintero, Ignacio Melero	103
11	Repurposing the yellow fever vaccine for intratumoral immunotherapy 2019 ·EMBO Molecular Medicine ·M. Ángela Aznar, Carmen Molina, Álvaro Teijeira, Inmaculada Rodríguez, Arantza Azpilikueta, Saray Garasa, Alfonso R. Sánchez-Paulete, (unknown), Iñaki Etxeberría, Maite Álvarez, (unknown), Estanislao Nistal‐Villán, Pedro Berraondo, Ignacio Melero	32
12	Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation 2018 ·Cancer Immunology Research ·Álvaro Teijeira, Sara Labiano, Saray Garasa, Iñaki Etxeberría, Eva Santamaría, Ana Rouzaut, Michel Enamorado, Arantza Azpilikueta, Susana Inogés, Elixabet Bolaños, M. Ángela Aznar, Alfonso R. Sánchez-Paulete, David Sancho, Ignacio Melero	65
13	ICAM-1-LFA-1 Dependent CD8+ T-Lymphocyte Aggregation in Tumor Tissue Prevents Recirculation to Draining Lymph Nodes 2018 ·Frontiers in Immunology ·(unknown), Saray Garasa, Álvaro Teijeira, Cristina Aubá, Ignacio Melero, Ana Rouzaut	32
14	CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell–Relevant Genes 2017 ·Cancer Immunology Research ·M. Ángela Aznar, Sara Labiano, Ángel Díaz‐Lagares, Carmen Molina, Saray Garasa, Arantza Azpilikueta, Iñaki Etxeberría, Alfonso R. Sánchez-Paulete, Alan J. Korman, Manel Esteller, Juan Sandoval, Ignacio Melero	35
15	Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15 2017 ·OncoImmunology ·María C. Ochoa, Luna Minute, (unknown), Elísabeth Pérez-Ruiz, (unknown), Marcos Vásquez, Susana Inogés, Iñaki Etxeberría, Inmaculada Rodríguez, Saray Garasa, (unknown), Peter Wirtz, Ignacio Melero, Pedro Berraondo	22
16	Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy 2017 ·Annals of Oncology ·Alfonso R. Sánchez-Paulete, Álvaro Teijeira, Francisco J. Cueto, Saray Garasa, José Luis Perez‐Gracia, Álvaro Sánchez-Arráez, David Sancho, Ignacio Melero	209
17	β3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells 2017 ·PLoS ONE ·Rafael Peláez, Xabier Morales, Elizabeth Salvo, Saray Garasa, Carlos Ortíz-de-Solórzano, Alfredo Martı́nez, Ignacio M. Larráyoz, Ana Rouzaut	29
18	Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming 2016 ·Cancer Research ·María E. Rodríguez-Ruiz, Inmaculada Rodríguez, Saray Garasa, Benigno Barbés, José Luis Solórzano, José Luis Perez‐Gracia, Sara Labiano, Miguel F. Sanmamed, Arantza Azpilikueta, Elixabet Bolaños, Alfonso R. Sánchez-Paulete, (unknown), Ana Rouzaut, Kurt A. Schalper, Maria Jure–Kunkel, Ignacio Melero	198
19	Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs) 2016 ·Clinical Cancer Research ·Carlos Alfaro, Álvaro Teijeira, Carmen Oñate, Guiomar Pérez, Miguel F. Sanmamed, Maria Pilar Andueza, Diego Alignani, Sara Labiano, Arantza Azpilikueta, Alfonso Rodriguez-Paulete, Saray Garasa, Juan P. Fusco, Ángela Aznar, Susana Inogés, Maria De Pizzol, Marcello Allegretti, José Medina‐Echeverz, Pedro Berraondo, José Luis Perez‐Gracia, Ignacio Melero	316
20	Segmentation and Shape Tracking of Whole Fluorescent Cells Based on the Chan–Vese Model 2013 ·IEEE Transactions on Medical Imaging ·Martin Maška, (unknown), Saray Garasa, Ana Rouzaut, (unknown), Carlos Ortíz-de-Solórzano	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact